896757004: Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug)

• SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...
• \Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing transferase inhibitor (product)\Product containing phosphotransferase inhibitor (product)\Product containing protein kinase inhibitor (product)\Trastuzumab emtansine-containing product\Trastuzumab emtansine-containing product in parenteral dose form\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)\Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial\Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug)
• \Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing transferase inhibitor (product)\Product containing phosphotransferase inhibitor (product)\Product containing protein kinase inhibitor (product)\Trastuzumab emtansine-containing product\Trastuzumab emtansine only product\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)\Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial\Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug)
• \Medicinal product categorized by disposition (product)\Product containing immunomodulator (product)\Trastuzumab emtansine-containing product\Trastuzumab emtansine-containing product in parenteral dose form\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)\Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial\Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug)
• \Medicinal product categorized by disposition (product)\Product containing immunomodulator (product)\Trastuzumab emtansine-containing product\Trastuzumab emtansine only product\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)\Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial\Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug)
• \Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing polypeptide (product)\Product containing protein (product)\Product containing antibody (product)\Product containing monoclonal antibody (product)\Trastuzumab emtansine-containing product\...
• \Trastuzumab emtansine-containing product in parenteral dose form\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)\Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial\Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug)
• \Trastuzumab emtansine only product\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)\Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial\Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug)
• \Product manufactured as parenteral dose form (product)\Trastuzumab emtansine-containing product in parenteral dose form\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)\Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial\Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
4029093012	Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4029094018	Trastuzumab emtansine 160 mg powder for solution for infusion vial	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core

Expanded Value Set

This concept is not in any reference sets

Back to Start